The NHS now has a national genomic laboratory service delivered through 7 regional Genomic Laboratory Hubs (GLH) which will support the delivery of the new National Genomic Test Directory. This network will improve standardisation of genomic testing and ensure equity of access for patients diagnosed with cancer in Greater Manchester.
The National Genomic Test Directory for solid tumours and rare/inherited disease went live on the 1st April 2021. The directory specifies which genomic tests are commissioned by the NHS in England, the technology by which they are available, and the patients who will be eligible to access to a test. You can find the directories here: https://www.england.nhs.uk/publication/national-genomic-test-directories/
Following the launch of the National Test Directory, local multidisciplinary teams are now able to request genetic testing for eligible patients diagnosed with breast cancer. This should enable quicker diagnosis for patients and support timely treatment planning.